What is Organ Care System Market?
An organ care system is a medical device that allows the donor organ to preserve for a longer period of time and it can be used during transplantation. The Organ Care System (OCS) is convenient organ perfusion and checking framework planning to protect a given organ in a near-normal physiologic beating state amid transport for possible transplantation into a beneficiary. The Organ Care System (OCS) is convenient organ perfusion and monitoring system aiming to protect a given organ in a near-normal physiologic beating state amid transport for possible transplantation into a beneficiary. The blood is collected from the giver and persistently circulated to the organ in a closed circuit together with the Arrangement. The Organ Care System preserves and screens the organ's perfusion and metabolic state after clarification from a giver and connection to the device, amid transportation to the beneficiary location, and until disconnection from the gadget. The system apportions with the conventional strategy of protecting organs through solidifying, supplanting it with keeping them in an environment and temperature comparable to that of the human body by perfusing the blood of the benefactor through the organs. The innovation behind all the organ care systems is about the same. All the frameworks comprise a least a single or more pump unit. The larger part of organ care frameworks has thermos units and workbenches or trolleys. In expansion to this, these frameworks moreover give ideal apparatuses for conservation, re-conditioning, and pre-conditioning. The primary difference in each system depends upon the sort of organ it is planned for. Organ care frameworks are outlined to improve the time frame for the conservation of organs outside of the body. These frameworks can lookout for organs till they are required for the transplantation. The organ care framework offers significant benefits to doctors, third-party payers, and most imperatively to patients. It moreover makes a difference within the conservation of giver organs at the time and makes strides in their quality over time.
The market study is being classified, by Application (Transplant Centers and Hospitals) and major geographies with country level break-up.
TransMedics Group (United States), XVIVO Perfusion AB (Sweden), Organ Assist B.V. (Netherlands), Lifeline Scientific, Inc (United States), Organ Transport System Inc. (United States), Water Medical System LLC (United States), Paragonix Technologies Inc. (United States), OrganOx Limited (United Kingdom), Preservation Solution Inc. (United States) and Bridge to Life Ltd. (United Kingdom) are some of the key players profiled in the study.
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Organ Care System market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Organ Care System market by Type, Application and Region.
On the basis of geography, the market of Organ Care System has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rising Cases of Ill Health from the Geriatric Population
- A Rise in Organ Transplant Operations
- Increasing Incidences of Death Due To Organ Failure
- Rising Trend towards Creating Awareness about Organ Donation
- Stringent rules & Regulations by the Government
- Advancement in the Technologies
- Increase in Research and Development Activities
- Lack of Appropriate Hospital Facilities
In June 2019, TransMedics also announced that the company has been successful in getting pre-market approval from the US FDA to expand the indication for its organ care system for lung preservation. The company also received pre-market approval for an ex-vivo assessment system to initially involve lung donors who are deemed unacceptable for transplantation because of the limitations on cold storage.
Key Target AudienceProviders of Organ Care System, End-Users, Potential Investors, Market Research Firms and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase